Abstract
Purpose
Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (fSRT) are noninvasive therapies for vestibular schwannomas providing excellent tumor control. However, delayed hearing loss after radiation therapy remains an issue. One potential target to for improving hearing rates is limiting radiation exposure to the cochlea.
Methods
We retrospectively reviewed 100 patients undergoing either SRS with 12 Gy (n = 43) or fSRT with 50 Gy over 28 fractions (n = 57) for vestibular schwannoma. Univariate and multivariate analysis were carried out to identify predictors of hearing loss as measured by the Gardner Robertson scale after radiation therapy.
Results
Deterioration of hearing occurred in 30% of patients with SRS and 26% with fSRT. The overall long term (> 2 year) progression rates were 20% for SRS and 16% for fSRT. Patients with a decrease in their Gardner Robertson hearing score and those that loss serviceable hearing had significantly higher average minimal doses to the cochlea in both SRS and fSRT cohorts. ROC analysis showed that a cut off of 5 Gy and 35 Gy, for SRS and fSRT respectively, predicted hearing loss with high sensitivity/specificity.
Conclusion
Our data suggests the minimal dose of radiation that the cochlear volume is exposed to is a predictor of delayed hearing loss after either SRS or fSRT. A threshold of 5 Gy/35 Gy may lead to improved hearing preservation after radiotherapy. Further prospective multi center studies can further elucidate this mechanism.
Similar content being viewed by others
References
Pinna MH, Bento RF, Neto RV (2012) Vestibular schwannoma: 825 cases from a 25-year experience. Int Arch Otorhinolaryngol 16:466–475. https://doi.org/10.7162/S1809-97772012000400007
Arthurs BJ, Lamoreaux WT, Mackay AR et al (2011) Gamma knife radiosurgery for vestibular schwannomas: tumor control and functional preservation in 70 patients. Am J Clin Oncol 34:265–269. https://doi.org/10.1097/COC.0b013e3181dbc2ab
Persson O, Bartek J, Shalom NB et al (2017) Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochir 159:1013–1021. https://doi.org/10.1007/s00701-017-3164-6
Rykaczewski B, Zabek M (2014) A meta-analysis of treatment of vestibular schwannoma using Gamma Knife radiosurgery. Contemp Oncol 18:60–66. https://doi.org/10.5114/wo.2014.39840
Mulder JJS, Kaanders JH, van Overbeeke JJ, Cremers CWRJ (2012) Radiation therapy for vestibular schwannomas. Curr Opin Otolaryngol Head Neck Surg 20:367–371. https://doi.org/10.1097/MOO.0b013e328357d337
Delbrouck C, Hassid S, Massager N et al (2003) Preservation of hearing in vestibular schwannomas treated by radiosurgery using leksell gamma knife: preliminary report of a prospective Belgian clinical study. Acta Otorhinolaryngol Belg 57:197–204
Paek SH, Chung H-T, Jeong SS et al (2005) Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer 104:580–590. https://doi.org/10.1002/cncr.21190
Massager N, Nissim O, Delbrouck C et al (2006) Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery. Int J Radiat Oncol Biol Phys 64:1331–1340. https://doi.org/10.1016/j.ijrobp.2005.10.030
Linskey ME, Johnstone PAS (2003) Radiation tolerance of normal temporal bone structures: implications for gamma knife stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 57:196–200
Massager N, Nissim O, Delbrouck C et al (2013) Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg 119(Suppl):733–739
Thomas C, Di Maio S, Ma R et al (2007) Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg 107:917–926. https://doi.org/10.3171/JNS-07/11/0917
Rasmussen R, Claesson M, Stangerup S-E et al (2012) Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss. Int J Radiat Oncol Biol Phys 83:e607–611. https://doi.org/10.1016/j.ijrobp.2012.01.078
Baschnagel AM, Chen PY, Bojrab D et al (2013) Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery. J Neurosurg 118:571–578. https://doi.org/10.3171/2012.10.JNS12880
Jacob JT, Carlson ML, Schiefer TK et al (2014) Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery 74:466–474. https://doi.org/10.1227/NEU.0000000000000299 (discussion 474)
Kano H, Kondziolka D, Khan A et al (2013) Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma: clinical article. J Neurosurg 119:863–873
Brown M, Ruckenstein M, Bigelow D et al (2011) Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Neurosurgery 69:605–613. https://doi.org/10.1227/NEU.0b013e31821a42f3 (discussion 613–614)
Watanabe S, Yamamoto M, Kawabe T et al (2016) Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. J Neurosurg 125:64–72. https://doi.org/10.3171/2016.7.GKS161494
Pan CC, Eisbruch A, Lee JS et al (2005) Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61:1393–1402. https://doi.org/10.1016/j.ijrobp.2004.08.019
Chung LK, Ung N, Sheppard JP et al (2018) Impact of cochlear dose on hearing preservation following stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of vestibular schwannoma. J Neurol Surg B 79:335–342. https://doi.org/10.1055/s-0037-1607968
Pacholke HD, Amdur RJ, Schmalfuss IM et al (2005) Contouring the middle and inner ear on radiotherapy planning scans. Am J Clin Oncol 28:143–147
Ikonomidis C, Pica A, Bloch J, Maire R (2015) Vestibular schwannoma: the evolution of hearing and tumor size in natural course and after treatment by LINAC stereotactic radiosurgery. Audiol Neurootol 20:406–415. https://doi.org/10.1159/000441119
Akpinar B, Mousavi SH, McDowell MM et al (2016) Early radiosurgery improves hearing preservation in vestibular schwannoma patients with normal hearing at the time of diagnosis. Int J Radiat Oncol Biol Phys 95:729–734. https://doi.org/10.1016/j.ijrobp.2016.01.019
Aoyama H, Onodera S, Takeichi N et al (2013) Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience. Int J Radiat Oncol Biol Phys 85:329–334. https://doi.org/10.1016/j.ijrobp.2012.05.003
Okunaga T, Matsuo T, Hayashi N et al (2005) Linear accelerator radiosurgery for vestibular schwannoma: measuring tumor volume changes on serial three-dimensional spoiled gradient-echo magnetic resonance images. J Neurosurg 103:53–58. https://doi.org/10.3171/jns.2005.103.1.0053
Hanna GG, Murray L, Patel R et al (2018) UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol 30:5–14. https://doi.org/10.1016/j.clon.2017.09.007
Lambrecht M, Eekers DBP, Alapetite C et al (2018) Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus. Radiother Oncol 128:26–36. https://doi.org/10.1016/j.radonc.2018.05.001
Lee T-F, Yeh S-A, Chao P-J et al (2015) Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy. Radiat Oncol 10:194. https://doi.org/10.1186/s13014-015-0501-x
Funding
Isaac Yang was partially supported by a Visionary Fund Grant, an Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA Scholars in Translational Medicine Program Award, the Jason Dessel Memorial Seed Grant, the UCLA Honberger Endowment Brain Tumor Research Seed Grant, and the STOP CANCER Research Career Development Award. The remaining authors have no disclosures or conflicts-of-interest.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Patel, K.S., Ng, E., Kaur, T. et al. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma. J Neurooncol 145, 329–337 (2019). https://doi.org/10.1007/s11060-019-03299-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-019-03299-5